0001666071-20-000306.txt : 20201216 0001666071-20-000306.hdr.sgml : 20201216 20201216183000 ACCESSION NUMBER: 0001666071-20-000306 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201214 FILED AS OF DATE: 20201216 DATE AS OF CHANGE: 20201216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Laube Lynne Marie CENTRAL INDEX KEY: 0001730687 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 201393676 MAIL ADDRESS: STREET 1: C/O CARDLYTICS, INC. STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-798-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 wf-form4_160816138763891.xml FORM 4 X0306 4 2020-12-14 0 0001666071 Cardlytics, Inc. CDLX 0001730687 Laube Lynne Marie C/O CARDLYTICS, INC. 675 PONCE DE LEON AVENUE NE, SUITE 6000 ATLANTA GA 30308 1 1 0 0 Chief Executive Officer Common Stock 2020-12-14 4 S 0 752 134.34 D 306254 D Common Stock 2020-12-14 4 S 0 848 135.36 D 305406 D Common Stock 2020-12-14 4 S 0 1612 136.44 D 303794 D Common Stock 2020-12-14 4 S 0 3692 137.53 D 300102 D Common Stock 2020-12-14 4 S 0 2896 138.34 D 297206 D Common Stock 2020-12-14 4 S 0 200 139.07 D 297006 D Common Stock 14565 I See Footnote Common Stock 14565 I See Footnote This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $133.82 to $134.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8) to this Form 4. Includes 158 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $134.89 to $135.80, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $135.90 to $136.80, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $136.94 to $137.93, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $137.95 to $138.91, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $139.03 to $139.11, inclusive. The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright. The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright. /s/ Kirk Somers, Attorney-in-Fact 2020-12-16